References
MacCarty RL, LaRusso NF, Wiesner RH, Ludwig J (1983) Primary sclerosing cholangitis: Findings on cholangiography and pancreatography Radiology 149:39–44
Chapman RW (1991) Aetiology and natural history of primary sclerosing cholangitis: A decade of progress? Gut 32:1433–1435
Chapman RW, Varghese Z, Gaul R, Kokkinon N, Sherlock S (1983) Association of primary sclerosing cholangitis with HLA B8. Gut 24:38–41
Schrumpf E, Fausa O, Gorre O, Doblong JH, Ritland S, Thorsby E (1982) HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 17:187–191
Lillemoe KD, Pitt HA, Cameron JL (1990) Primary sclerosing cholangitis. Surg Clin North Am 70:1381–1402
Chapman RW, Kelly PMA, Heryet A, Jewell DP, Fleming KA (1988) Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29:422–427
Bodenheimer HCJ, LaRusso NF, Thayer WR, Charland C, Staples PJ, Ludwig, J (1983) Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 3:150–154
Snook JA, Chapman RW, Fleming KA, Jewell DP (1989) Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 76:30–33
Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH (1992) Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33:657–662
Kemeny MM, Battifora H, Blayney DW, Cecchi G, Goldberg DA, Leong LA, Margolin KA, Terz JJ (1985) Selerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 202:176–181
Thompson HH, Pitt HA, Tompkins RK, Longmire WP Jr (1982) Primary sclerosing cholangitis: A heterogeneous disease. Ann Surg 196:127–136
Cello JP (1989) Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease. Am J Med 86:539–546
Demetris AJ, Lasky S, Van Thiel DJ, Starzl TE, Dekker A (1985) Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol 118:151–161
Dickson ER, Murtaugh PA, Wiesner RH, Grambasch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, Maddrey WC, Williams R, Farrant M, Langworthy A (1992) Primary sclerosing cholangitis: Refinement validation of survival models. Gastroenterology 103: 1893–1901
Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, Krom RAF (1992) Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 16:1290–1299
Cameron JL, Pitt HA, Zinner MJ, Herlong JF, Kaufman SL, Boitnott JK, Coleman J (1988) Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis, Ann Surg 207:614–622
Chapman RW, Marborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S (1980) Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology Gut 21:870–877
Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT, (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis Hepatology 1:632–640
Helzberg JH, Petersen JM, Boyer JL (1987) Improved survival with primary sclerosing cholangitis: A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients, Gastroenterology 92: 1869–1875
Fausa O, Schrumpf E, Elgjo K (1991) Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 11:31–39
Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: A long-term follow-up study. Scand J Gastroenterol 22:655–664
Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel H (1990) Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of 66 subjects. Hepatology 11:7–11
Broomé U, Lindberg G, Löfberg R (1992) Primary sclerosing cholangitis in ulcerative colitis: A risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 102: 1877–1880
Rosen CB, Nagorney DM (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 11:26–30
Cangemi JR, Wiesner RH, Beaver SJ, Ludwig J, MacCarty RL, Dozois RR, Zinsmeister AR, LaRusso NF (1989) Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 96:790–794
Kartheuser AH, Dozois RR, Wiesner RH, LaRusso NF, Illstrup DM, Schleck CD (1993) Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg 217:314–320
Abu-Elmagd KM, Selby R, Iwatsuki S, Fung J, Tzakis A, Todo S, Demetris AJ, Baddour N, Irish W, Van Thiel DH, Starzl TE (1993) Cholangiocarcinoma and sclerosing cholangitis: Clinical characteristics and effect on survival after liver transplantation. Transplant Proc 25:1124–1128
Farges O, Malassagne B, Sebaugh M, Bismuth H (1995) Primary sclerosing cholangitis: Liver transplantation or biliary surgery. Surgery 117:146–155
Rosen CR, Nagorney DM, Wiesner RH, Coffey RJ, LaRusso NF (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213:21–25
Cameron JL, Gayler BW, Sanfey H, Milligan F, Kaufman S, Maddrey WC, Herlong HF (1984) Sclerosing cholangitis: Anatomical distribution of obstructive lesions. Ann Surg 200:54–60
Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R (1995) Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108:865–869
Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr (1993) Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 68:874–879
Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA (1996) Biliary CEA levels are a marker for cholangiocarcinoma. Am J Surg 171:147–153
Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1989) Primary sclerosing cholangitis: Natural history, prognostic factors, and survival analysis. Hepatology 10:430–436
Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, Twomey CK, Zinsmeister AR (1990) Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 98:1594–1602
Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R (1991) Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710–1717
Muller EL, Miyamoto T, Pitt HA, Longmire WP Jr (1985) Anatomy of the choledochopancreatic duct junction in primary sclerosing cholangitis. Surgery 97:21–26
Kaplan MM (1991) Medical approaches to primary sclerosing cholangitis. Semin Liver Dis 11:56–63
Wiesner RH, Steiner B, LaRusso NF, Lindor KD, Baldus WP (1991) A controlled trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis (abstract). Hepatology 14:63
O'Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G (1991) Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study. Hepatology 14:838–847
Kaplan MM, Arora S, Pincus SH (1987) Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Ann Intern Med 106:231–235
Beuers U, Spenger U, Kruis W, Aydemir U, Wiebecke B, Heldwein W (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial. Hepatology 16:707–714
Knox T, Kaplan MM (1994) A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 106:494–499
Lee JG, Schutz SM, England RE, Leung JW, Cotton PB (1995) Endoscopic therapy of sclerosing cholangitis. Hepatology 21: 661–667
Johnson GK, Geenen JE, Venu RP, Schmalz MJ, Hogan WJ (1991) Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: A larger series and recommendations for treatment. Gastrointest Endosc 37:38–43
Mueller PR, vanSonnenberg E, Ferruci JT, Weyman PJ, Butch RJ, Malt RA, Burhenne HJ (1986) Biliary stricture dilatation: Multicenter review of clinical management of 73 patients. Radiology 160:17–22
Cameron JL, Gayler BW, Herlong JF, Maddrey WC (1983) Sclerosing cholangitis: Biliary reconstruction with Silastic transhepatic stents. Surgery 94:324–330
Ahrendt SA, Pitt HA, Kalloo AN, Venbrux A, Klein AS, Herlong JF, Coleman J, Lillemoe KD, Cameron JL (1995) Primary sclerosing cholangitis: Resect, dilate, or transplant (abstract)?, Gastroenterology 108:1211
Ahrendt SA, Pitt HA, Kalloo AN, Venbrux A, Klein AS, Herlong JF, Coleman J, Lillemoe KD, Cameron JL (1995) Management of primary sclerosing cholangitis in the 1990s (abstract). Hepatology 22:107
Cameron JL (1990) Atlas of surgery, vol 1 B.C. Decker, Philadelphia, pp 94–115
Marsh JW, Iwatsuki S, Makowka L, Esquirel CO, Gordon RD, Todo S, Tsakis A, Miller C, Van Thiel D, Starzl TE (1988) Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 207:21–25
Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, Krom RAF, Van Thiel DJ, Starzl TE (1993) Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 177:335–344
Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL (1995) Liver transplantation for sclerosing cholangitis. Hepatology 22:451–457
Strasser S, Sheil AGR, Gallagher ND, Waugh R, McCaughan GW (1993) Liver transplantation for primary sclerosing cholangitis versus primary biliary cirrhosis: A comparison of complications and outcome. J Gastroenterol Hepatol 8:238–243
Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R (1991) Predieting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 32:1369–1373
Shaked A, Colonna JO, Goldstein L, Busuttil RW (1992) The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 215:598–605
Author information
Authors and Affiliations
About this article
Cite this article
Ahrendt, S.A., Pitt, H.A. Sclerosing cholangitis. J Hep Bil Pancr Surg 3, 431–441 (1996). https://doi.org/10.1007/BF02349788
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02349788